Marjatta K. Repo-Leirisalo

Helsinki, 00290, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 73 publications

CMR T1 and T2 mapping and extracellular volume quantification in systolic phase produces superior image quality with less motion artifacts and equal mapping values compared to conventional diastolic mapping.

CMR T1 and T2 mapping and extracellular volume quantification in systolic phase produces superior image quality with less motion artifacts and equal mapping values compared to conventional diastolic mapping.

Journal: Magma (New York, N.Y.)

Published: November 14, 2025

Signalling profile of circulating leucocytes of subjects with Raynaud's phenomenon in relation to systemic sclerosis: a pilot study.

Signalling profile of circulating leucocytes of subjects with Raynaud's phenomenon in relation to systemic sclerosis: a pilot study.

Journal: Scandinavian journal of rheumatology

Published: November 04, 2025

Limited reduction of bone mineral density in patients with early rheumatoid arthritis receiving aggressive treatment: 10 year results of the NEO-RACo study.

Limited reduction of bone mineral density in patients with early rheumatoid arthritis receiving aggressive treatment: 10 year results of the NEO-RACo study.

Journal: Scandinavian journal of rheumatology

Published: June 23, 2025

Clonal hematopoiesis is associated with distinct rheumatoid arthritis phenotypes.

Clonal hematopoiesis is associated with distinct rheumatoid arthritis phenotypes.

Journal: Science advances

Published: April 30, 2025

Do infections play a role in the development of chronic inflammatory arthritis? A 14-year follow-up study of patients with early arthritis.

Do infections play a role in the development of chronic inflammatory arthritis? A 14-year follow-up study of patients with early arthritis.

Journal: BMC rheumatology

Published: November 02, 2024

The impact of autoantibodies on the efficacy of biological disease-modifying anti-rheumatic drugs in rheumatoid arthritis: meta-analysis of randomized controlled trials.

The impact of autoantibodies on the efficacy of biological disease-modifying anti-rheumatic drugs in rheumatoid arthritis: meta-analysis of randomized controlled trials.

Journal: Rheumatology (Oxford, England)

Published: September 26, 2023

Myocardial T1 mapping by cardiac magnetic resonance imaging shows early myocardial changes in treatment-naive patients with active rheumatoid arthritis and positive autoantibodies.

Myocardial T1 mapping by cardiac magnetic resonance imaging shows early myocardial changes in treatment-naive patients with active rheumatoid arthritis and positive autoantibodies.

Journal: Clinical and experimental rheumatology

Published: August 29, 2023

The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis.

The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis.

Journal: Arthritis research & therapy

Published: May 17, 2022

Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response.

Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response.

Journal: Clinical and experimental immunology

Published: April 19, 2022

Pretreatment resistin levels are associated with erosive disease in early rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs and infliximab.

Pretreatment resistin levels are associated with erosive disease in early rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs and infliximab.

Journal: Scandinavian journal of rheumatology

Published: July 15, 2021

Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis In Vivo and Baseline Signaling Profile Associates With Treatment Response.

Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis In Vivo and Baseline Signaling Profile Associates With Treatment Response.

Journal: Frontiers in immunology

Published: July 08, 2021

Corrigendum: Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte Signature.

Corrigendum: Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte Signature.

Journal: Frontiers in immunology

Published: May 17, 2021

Showing 1-12 of 73

Last Updated: 09/26/2026